Quantcast

Latest Clinical trial Stories

2014-10-02 08:24:49

LUGANO, Switzerland, October 2, 2014 /PRNewswire/ -- Rare cancer patients need access to innovative cancer drugs A consensus paper published in the Annals of Oncology today by Rare Cancers Europe (RCE) calls for new methodologies to be applied to clinical studies in rare cancers. RCE - a multi-stakeholder initiative representing patient associations, medical societies and industry - is calling both the community of researchers and European authorities to address...

2014-10-02 00:21:35

-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications. All endpoints were met regarding HbA1c and weight reductions, as well as the percent of patients treated to goal. Pre-specified sub-group analyses on HbA1c reductions over time also showed clinically and statistically significant impact across a wide spectrum of patients and background medications. Significant HbA1c reductions were observed over the 39 weeks ranging from a...

2014-10-01 23:08:17

Clinical Conductor CTMS and OpenClinica officially announce a newly formed strategic partnership, and beginning immediately, Clinical Conductor CTMS will begin including OpenClinica Enterprise EDC as part of its product offerings. Rochester, NY (PRWEB) October 01, 2014 Clinical Conductor CTMS, the leading clinical trial management system, and OpenClinica, one of the world's most widely adopted electronic data capture (EDC) software platforms, are pleased to announce the formation of a...

2014-10-01 23:08:10

We’re pleased to announce that RPM Alliance is our newest partner San Francisco, CA (PRWEB) October 01, 2014 Medrio, a leading provider of eClinical Software as a Service (SaaS) for clinical research, announced today that RPM Alliance, providers of clinical research and data management services to biotech and pharmaceutical companies, have joined Medrio’s Partner Program. “We are delighted to add RPM Alliance to our Partner Program,” says Scott Weidley, VP of Sales and Marketing...

2014-10-01 16:26:43

Global Clinical Trials Get Breakthrough Technology to Improve Signal Detection HAMILTON, N.J., Oct. 1, 2014 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders, announced the deployment of its groundbreaking Virgil Investigative Study Platform in multiple clinical trials worldwide. The Virgil platform, developed specifically for investigative sites,...

2014-10-01 12:31:51

--- CCPME is a fund jointly set up by the Caisse de dépôt et placement du Québec ("CDPQ") and by Capital régional et coopératif Desjardins ("CRCD") --- MONTREAL, Oct. 1(st) 2014 /CNW Telbec/ - JSS Medical Research Inc., a Montreal based Contract Research Organization (CRO), conducting Phase I - IV Clinical Trials, Post Marketing Observational Studies as well as Epidemiological and Health Economics Research for Pharmaceutical, Biotechnology and Device companies, announced today...

2014-10-01 12:31:29

SAN FRANCISCO, Oct 1, 2014 /PRNewswire/ -- In the world of mobile technology we have an app for everything, but mission-critical information about the clinical trials that physicians are managing seems to be in the prehistoric days. Clinical trials have inherently become more complex over the years, especially with infectious disease, cardiovascular, oncology and CNS trials. The number of vendors and pharmaceutical company contacts have soared - the average study has 30+ contacts...

2014-10-01 08:31:55

ANTWERP, Belgium and NEW YORK, October 1, 2014 /PRNewswire/ -- genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced today the expansion of its North American activities with the opening of offices in New York City. genae Americas was incorporated in 2011. "New York City is strategically centered in one of the highest concentrations of medical innovation and leading research facilities on the East Coast", said...

2014-10-01 08:30:24

-- Primary endpoint was met for 50 mg twice daily dosing -- FREMONT, Calif., Oct. 1, 2014 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C). Results from this study demonstrated statistically significant and...

2014-09-30 23:19:33

Clinovo’s ClinCapture® system will provide ease of use and advanced functionality for Synergy MOSCOW, Russia (PRWEB) September 30, 2014 In a move that will deliver advanced functionality, as well as better data capture and management functions for sponsors, Synergy Research Group has chosen Clinovo’s ClinCapture electronic data capture (EDC) system. ClinCapture offers advanced out-of-the-box features that will give Synergy the ability to easily manage clinical trial data and...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.